Most opponents of the pharmaceutical industry's structure want the FDA, NIH, or government to run industrial policy by choosing which drug pathways to pursue, and that approach always loses to decentralized information because bureaucracy is sluggish.

normativepending

Speaker

Richard Epstein

Evidence Quote

“Decentralized information will trump centralized control with all of its bureaucratic sluggishness every time out of the box.”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...